Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: A randomized phase II study

British Journal of Dermatology

Volumn 149, Issue 3, 2003, Pages 590-597

  Nagl, M ^a   Nguyen, V A ^b   Gottardi, W ^a   Ulmer, H ^a   HoPfl R ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Chloramine T; Leg ulcer; N chlorotaurine; Randomized phase II study; Wound healing

Indexed keywords

N CHLOROTAURINE; TAURINE DERIVATIVE; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG;

ADULT; AGED; AQUEOUS SOLUTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CARCINOMA CELL; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EPITHELIZATION; FEMALE; GRANULATION TISSUE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEG ULCER; MALE; MICROBIOLOGICAL EXAMINATION; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SMEAR; SQUAMOUS CELL CARCINOMA; TISSUE NECROSIS; TOXICITY TESTING; WOUND DRESSING;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; CHLORAMINES; CHRONIC DISEASE; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG EVALUATION; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; PAIN; TAURINE; TOSYL COMPOUNDS; TREATMENT OUTCOME; WOUND HEALING;

EID: 0142057197     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05432.x     Document Type: Article

References (34)

1. Paquette D, Falanga V. Leg ulcers. Clin Geriatr Med 2002; 18: 77-88.
2. Valencia IC, Falabella A, Kirsner RS et al. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 2001; 44: 401-21.
3. Fumal I, Braham C, Paquet P et al. The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-concept study. Dermatology 2002; 204 (Suppl. 1): 70-4.
4. Daroczy J. Antiseptic efficacy of local disinfecting povidone-iodine (Betadine®) therapy in chronic wounds of lymphedematous patients. Dermatology 2002; 204 (Suppl. 1): 75-8.
5. Hansson C, Faergemann J. The effect of antiseptic solutions on microorganisms in venous leg ulcers. Acta Derm Venereol (Stockh) 1995; 75: 31-3.
6. Dychdala GR. Chlorine and chlorine compounds. In: Disinfection, Sterilization and Preservation (Block SS, ed.). 5th edn. Philadelphia: Lippincott, Williams & Wilkins 2001, 135-58.
7. Henderson JD Jr. Leming JT, Melon-Niksa DB. Chloramine-T solutions: effect on wound healing in guinea pigs. Arch Phys Med Rehabil 1989; 70: 628-31.
8. Edlich RF, Custer J, Madden J et al. Studies in management of the contaminated wound. 3. Assessment of the effectiveness of irrigation with antiseptic agents. Am J Surg 1969; 118: 21-30.
9. Weiss SJ, Klein R, Slivka A et al. Chlorination of taurine by human neutrophils. J Clin Invest 1982; 70: 598-607.
10. Thomas EL. Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: effect of exogenous amines on the antibacterial action against Escherichia coli. Infect Immun 1979; 25: 110-16.
11. Passo SA, Weiss SJ. Oxidative mechanisms utilized by human neutrophils to destroy Escherichia coli. Blood 1984; 63: 1361-8.
12. Nagl M, Hess M, Pfaller K et al. Bactericidal activity of micromolar N-chlorotaurine - evidence for its antimicrobial function in the human defence system. Antimicrob Agents Chemother 2000; 44: 2507-13.
13. Nagl M, Gottardi W. Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med 1996; 21: 597-605.
14. Gottardi W, Hagleitner M, Nagl M. The influence of plasma on the disinfecting activity of the new antimicrobial agent N-chlorotaurine sodium. J Pharm Pharmacol 2001; 53: 689-97.
15. Nagl M, Gruber A, Fuchs A et al. Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp. Antimicrob Agents Chemother 2002; 46: 1996-9.
16. Nagl M, Lass-Floerl C, Neher A et al. Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother 2001; 47: 871-4.
17. Nagl M, Larcher C, Gottardi W. Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res 1998; 38: 25-30.
18. Liu Y, Quinn MR. Chemokine production by rat alveolar macrophages is inhibited by taurine chloramine. Immunol Lett 2002; 80: 27-32.
19. Barua M, Liu Y, Quinn MR. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 2001; 167: 2275-81.
20. Marcinkiewicz J. Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today 1997; 18: 577-80.
21. Park E, Levis WR, Quinn MR et al. Regulation of nitric oxide induced by mycobacterlal lipoarabinomannan in murine macrophages: effects of interferon-beta and taurine-chloramine. Int J Lepr Other Mycobact Dis 2000; 68: 444-51.
22. Kontny E, Grabowska A, Kowalczewski J et al. Taurine chloramine inhibition of cell proliferation and cytokine production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 1999; 42: 2552-60.
23. Marcinkiewicz J, Nowak B, Grabowska A et al. Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunology 1999; 98: 371-8.
24. Nagl M, Miller B, Daxecker F et al. Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye - a phase I clinical study. J Ocular Pharmacol Ther 1998; 14: 283-90.
25. Nagl M, Teuchner B, Pöttinger E et al. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study. Ophthalmologica 2000; 214: 111-14.
26. Nagl M, Pfausler B, Schmutzhard E et al. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zbl Bakteriol 1998; 288: 217-23.
27. Unterberger I, Spiss H, Brandauer E et al. N-chlorotaurine - local antibacterial therapy in urinary tract infections by omniresistant Pseudomonas aeruginosa. In: 21st Annual Conference of the Arbeitsgemeinschaft Neurologische Intensivmedizin (ANIM) 18 January 2001, Innsbruck, Austria.
28. Neher A, Nagl M, Schrott-Fischer A et al. N-chlorotaurine, a novel endogenous antimicrobial agent: tolerability tested in a mouse model. Arch Otolaryngol Head Neck Surg 2001; 127: 530-3.
29. Tatsumi T, Fliss H. Hypochlorous acid and chloramines increase endothelial permeability: possible involvement of cellular zinc. Am J Physiol 1994; 267: H1597-607.
30. Effenberger T. Chloramine T solution for intraoperative peritoneal lavage. A statistical analysis. Zentralbl Chir 1988; 113: 959-67.
31. Brennan SS, Leaper DJ. The effect of antiseptics on the healing wound: a study using the rabbit ear chamber. Br J Surg 1985; 72: 780-2.
32. Brennan SS, Foster ME, Leaper DJ. Antiseptic toxicity in wounds healing by secondary intention. J Hosp Infect 1986; 8: 263-7.
33. Schmidt K, Debus ES, Jessberger ST et al. Bacterial population of chronic crural ulcers: is there a difference between the diabetic, the venous, and the arterial ulcer? Vasa 2000; 29: 62-70.
34. Lawrynowicz R. Aerobic and anaerobic bacterial flora of crural ulcers. Przegl Dermatol 1988; 75: 439-43.